Company: OTSA
Filing Date: 2025-05-23
Form Type: DRS/A
Source: 0001213900-25-047247
Chunk: 224

Company: OTSAW Ltd
Filing Date: 2025-05-23
Form: DRS/A
Chunk 224
---
, respectively. **The amounts are total outstanding interest and principal. (Note 20 of audited financial statements) ***All related party transactions described above are denominated in USD. (1)Between financial year 2022 and 2024, Otsaw Group sold goods and services to Swisslog Healthcare AG Branch Italy, Swisslog Healthcare AG Branch Netherlands, Swisslog UK, SAS Swisslog France and Activ Technology Group. (2)Between financial year 2022 and 2024, Otsaw Group purchased goods and services from Activ Technology Pte Ltd, Serial Microelectronics Pte Ltd, Swisslog Healthcare GmbH, Swisslog Healthcare AG Branch Germany, Swisslog Healthcare AG Branch Netherlands, Meyzer Management Advisory Pte Ltd and SG Networks Pte Ltd. (3)During financial year 2022, purchase of fixed asset from Activ Technology Pte Ltd. (4)During the year 2022, the Company obtained funds from Ararrat Capital Pte. Ltd., the Immediate and Ultimate Holding Company. The loan is unsecured, bears interest at 6% per annum and repayable on demand.

143 SHARES ELIGIBLE FOR FUTURE SALE Prior to this offering, there has been no market for our Class A Ordinary Shares. Future sales of substantial amounts of our Class A Ordinary Shares in the public market could adversely affect market prices prevailing from time to time. Furthermore, because only a limited number of Class A Ordinary Shares will be available for sale shortly after this offering due to existing contractual and legal restrictions on resale as described below, there may be sales of substantial amounts of our Class A Ordinary Shares in the public market after such restrictions lapse. This may adversely affect the prevailing market price of our Class A Ordinary Shares and our ability to raise equity capital in the future. Upon completion of this offering, we will have an aggregate of [•] Class A Ordinary Shares outstanding, including [•] Class A Ordinary Shares that we are selling in this offering, and [1] Class B Ordinary Share outstanding, assuming no exercise of the underwriters’ over -allotmentoption. Our Class A Ordinary Shares will be available for sale in the public market after the expiration or waiver of the lock -upagreements described below, subject to limitations imposed by U.S. securities laws on resale by our “affiliates” as that term is defined in Rule 144 under the Securities Act, or Rule 144. We expect that all of our Class A Ordinary Shares being sold in this offering by the Company will be freely tradable